關於 GLOBEIMMUNE INC
GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens. Tarmogens activate T cells to specifically target and eliminate diseased cells with the same target antigen.
Source: Wikipedia
產業Pharmaceuticals
總部Louisville, CO
成立時間1995
法律形式C Corporation
狀態營運中
專利20 項專利
YEAST-BRACHYURY IMMUNOTHERAPEUTIC COMPOSITIONSJP2019199484A · 2019
IMMUNOTHERAPEUTIC YEAST-MUC1 COMPOSITIONS AND USES THEREOFJP2019194261A · 2019
關鍵數據
法律資訊
| 法定名稱 | GLOBEIMMUNE INC |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1245104在 SEC EDGAR 上查看 ↗ |
| 登記地址 | Louisville, CO |
| 狀態 | 營運中 |
來源: SEC EDGAR · 更新於 2026年11月14日